Company Overview of Exicure Inc.
Exicure Inc. develops a new class of immunomodulatory and gene silencing drugs against validated targets. It uses spherical nucleic acid technology platform to build a pipeline of products for a range of diseases with unmet medical needs. The company addresses diseases, such as oncology, immunology, and dermatology. Exicure Inc. was formerly known as AuraSense Therapeutics, LLC. The company was founded in 2009 and is based in Skokie, Illinois.
8045 Lamon Avenue
Skokie, IL 60077
Founded in 2009
Key Executives for Exicure Inc.
Exicure Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
October 13, 2015
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Exicure Inc., please visit www.exicuretx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.